ArticleCarcinogenesis2014

EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.

Amber Bradley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.